Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Other companies in Aptevo Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), ABVC BioPharma (NASDAQ:ABVC), Portage Biotech (NASDAQ:PRTG), Viracta Therapeutics (NASDAQ:VIRX) and AquaBounty Techs (NASDAQ:AQB).
Aptevo Therapeutics has a consensus price target of $14.00.
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $0.28 last updated November 21, 2024 at 9:04 AM EST.
There are no upcoming dividends for Aptevo Therapeutics.
Aptevo Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Aptevo Therapeutics.
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.